Schwarzenegger backs stem cell plan
By Associated Press,
Associated Press
| 10. 19. 2004
SAN FRANCISCO, California (AP) -- Gov. Arnold Schwarzenegger has endorsed a $3 billion bond measure that would fund human embryonic stem cell research, a move that bucks Republican leaders and threatens to further strain the state's budget.
"California has always been a pioneer," Schwarzenegger said Monday. "We daringly led the way for the high-tech industry and now voters can help ensure we lead the way for the biotech industry."
The endorsement of the stem cell research measure comes at some political risk for the governor, who campaigned against California going deeper into debt when he unseated Gray Davis as governor in last year's recall election.
The endorsement also will put Schwarzenegger at odds with the state Republican Party, which officially opposes Proposition 71, and perhaps the Bush administration, which has limited federal funding of the research.
"It's a surprise given the economic challenges facing the state," said Jack Pitney, a political scientist at Claremont McKenna College who is voting against the measure.
"Social conservatives might be unhappy, too, but he was never their favorite anyway."
Schwarzenegger has said he supports...
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...